All‐trans‐retinoic acid in poems syndrome. Therapeutic effect associated with decreased circulating levels of proinflammatory cytokines
- 1 August 1996
- journal article
- case report
- Published by Wiley in Arthritis & Rheumatism
- Vol. 39 (8) , 1423-1426
- https://doi.org/10.1002/art.1780390824
Abstract
Chronically elevated serum levels of proinflammatory cytokines is a feature of the syndrome known as POEMS (plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, monoclonal [M] protein, skin changes). A patient had a POEMS syndrome with thrombocytosis and biclonal gammopathy and was treated as follows: all‐trans‐retinoic acid (tretinoin) at 90 mg/day for 50 days, no treatment for 70 days, readministration of tretinoin at 75 mg/day for 180 days. Focal bone lesion irradiation was performed from day 26 to day 50. Serum levels of interleukin‐6 (IL‐6), tumor necrosis factor a (TNFα), and IL‐1β normalized within 7 days after the first administration of tretinoin, transiently increased at the time of radiotherapy, increased again after withdrawal of the tretinoin, and decreased again after its reintroduction. The platelet count and gammopathy paralleled the changes in the cytokine levels. This study documents in vivo the ability of all‐trans‐retinoic acid to down‐regulate the release of IL‐6, IL‐1β, and TNFα, and illustrates its potential as a therapeutic agent in conditions associated with chronic overproduction of proinflammatory cytokines.Keywords
This publication has 15 references indexed in Scilit:
- Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndromeBlood, 1996
- Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule.Journal of Clinical Oncology, 1995
- Fuzzy classification of patient state with application to electrodiagnosis of peripheral polyneuropathyIEEE Transactions on Biomedical Engineering, 1995
- POEMS syndrome: A study of 25 cases and a review of the literatureThe American Journal of Medicine, 1994
- Early weight loss and high serum tumor necrosis factor‐α levels in polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes syndromeAnnals of Neurology, 1994
- Alleviation of Systemic Manifestations of Castleman's Disease by Monoclonal Anti-Interleukin-6 AntibodyNew England Journal of Medicine, 1994
- Stimulation of interleukin-1 alpha and interleukin-1 beta production in human monocytes by protein phosphatase 1 and 2A inhibitors.Journal of Biological Chemistry, 1993
- Plasma-Cell Dyscrasia with PolyneuropathyNew England Journal of Medicine, 1992
- Okadaic acid is a potent inducer of AP-1, NF-κB, and tumor necrosis factor-α in human B lymphocytesBiochemical and Biophysical Research Communications, 1992
- Plasma Exchange in Polyneuropathy Associated with Monoclonal Gammopathy of Undetermined SignificanceNew England Journal of Medicine, 1991